The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Fructose-1,6-bisphosphatase opposes renal carcinoma progression
Open accessAbstract
Clear cell renal cell carcinoma (ccRCC), the most common form of kidney cancer, is characterized by elevated glycogen levels and fat deposition. These consistent metabolic alterations are associated with normoxic stabilization of hypoxia-inducible factors (HIFs) secondary to von Hippel-Lindau (VHL) mutations that occur in over 90% of ccRCC tumours. However, kidney-specific VHL deletion in mice fails to elicit ccRCC-specific metabolic phenotypes and tumour formation, suggesting that additional mechanisms are essential. Recent large-scale sequencing analyses revealed the loss of several chromatin remodelling enzymes in a subset of ccRCC (these included polybromo-1, SET domain containing 2 and BRCA1-associated protein-1, among others), indicating that epigenetic perturbations are probably important contributors to the natural history of this disease. Here we used an integrative approach comprising pan-metabolomic profiling and metabolic gene set analysis and determined that the gluconeogenic enzyme fructose-1,6-bisphosphatase 1 (FBP1) is uniformly depleted in over six hundred ccRCC tumours examined. Notably, the human FBP1 locus resides on chromosome 9q22, the loss of which is associated with poor prognosis for ccRCC patients. Our data further indicate that FBP1 inhibits ccRCC progression through two distinct mechanisms. First, FBP1 antagonizes glycolytic flux in renal tubular epithelial cells, the presumptive ccRCC cell of origin, thereby inhibiting a potential Warburg effect. Second, in pVHL (the protein encoded by the VHL gene)-deficient ccRCC cells, FBP1 restrains cell proliferation, glycolysis and the pentose phosphate pathway in a catalytic-activity-independent manner, by inhibiting nuclear HIF function via direct interaction with the HIF inhibitory domain. This unique dual function of the FBP1 protein explains its ubiquitous loss in ccRCC, distinguishing FBP1 from previously identified tumour suppressors that are not consistently mutated in all tumours.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Hypoxia can provide energy to tumor cells by activating transcriptional programs that induce glucose uptake and glycolysis.”
From Hypoxia signaling in cancer: Implications for therapeutic interventions (2023) · cites this paper as [47]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
Gerlinger, M., Rowan, A. J., Horswell, S., Larkin, J., Endesfelder, D., Gronroos, E., Martinez, P., Matthews, N., Stewart, A., Tarpey, P., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1113205 · Cited by 7,774
Comprehensive molecular characterization of clear cell renal cell carcinoma
The Cancer Genome Atlas Research Network (2013) · Nature · doi:10.1038/nature12222 · Cited by 3,485
Hypoxia-inducible factors and the response to hypoxic stress
Majmundar, A. J., Wong, W. J., & Simon, M. C. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.09.022 · Cited by 2,380
Self-citationReductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia
Metallo, C. M., Gameiro, P. A., Bell, E. L., Mattaini, K. R., Yang, J., Hiller, K., Jewell, C. M., Johnson, Z. R., Irvine, D. J., Guarente, L., et al. (2012) · Nature · doi:10.1038/nature10602 · Cited by 1,791
HIF1α and HIF2α: sibling rivalry in hypoxic tumour growth and progression
Keith, B., Johnson, R. S., & Simon, M. C. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3183 · Cited by 1,693
Self-citationFunctional genomics reveal that the serine synthesis pathway is essential in breast cancer
Possemato, R., Marks, K. M., Shaul, Y. D., Pacold, M. E., Kim, D., Birsoy, K., Sethumadhavan, S., Woo, H.-K., Jang, H. G., Jha, A. K., et al. (2011) · Nature · doi:10.1038/nature10350 · Cited by 1,683
Rini, B. I., Campbell, S. C., & Escudier, B. J. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60229-4 · Cited by 1,634
Cohen, H. T., & McGovern, F. J. (2005) · New England Journal of Medicine · doi:10.1056/nejmra043172 · Cited by 1,591
Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma
Varela, I., Tarpey, P. S., Raine, K. M., Huang, D., Ong, C. K., Stephens, P., Davies, H. R., Jones, D., Lin, M., Teague, J. W., et al. (2011) · Nature · doi:10.1038/nature09639 · Cited by 1,302
Cited by
Sorted by citations
Items 501–550 of 550
Tang, Q., Yu, R., Wang, Y., Xie, F., Zhang, H., Wu, C., & Fang, M. (2024) · Figshare · doi:10.6084/m9.figshare.26598815
Xu, Y., Xia, D., Huang, K., & Liang, M. (2024) · Figshare · doi:10.6084/m9.figshare.26669397
Qianwei, X., Zeng, T., Liu, S., Cheng, H., Ma, L., & Wang, Y. (2021) · Figshare · doi:10.6084/m9.figshare.14396788
Tang, Q., Yu, R., Wang, Y., Xie, F., Zhang, H., Wu, C., & Fang, M. (2024) · Figshare · doi:10.6084/m9.figshare.26598818
Shi, Y., Li, K., Yuan, Y., Wang, C., Yang, Z., Zuo, D., Niu, Y., 邱际亮, Li, B., Yuan, Y., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25621966
Self-citationTang, Q., Yu, R., Wang, Y., Xie, F., Zhang, H., Wu, C., & Fang, M. (2024) · Figshare · doi:10.6084/m9.figshare.26598827
Shi, Y., Li, K., Yuan, Y., Wang, C., Yang, Z., Zuo, D., Niu, Y., 邱际亮, Li, B., Yuan, Y., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26707796
Self-citationXu, Y., Xia, D., Huang, K., & Liang, M. (2024) · Figshare · doi:10.6084/m9.figshare.26669385
Tang, Q., Yu, R., Wang, Y., Xie, F., Zhang, H., Wu, C., & Fang, M. (2024) · Figshare · doi:10.6084/m9.figshare.26598809
Shi, Y., Li, K., Yuan, Y., Wang, C., Yang, Z., Zuo, D., Niu, Y., 邱际亮, Li, B., Yuan, Y., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26707799
Self-citationTang, Q., Yu, R., Wang, Y., Xie, F., Zhang, H., Wu, C., & Fang, M. (2024) · Figshare · doi:10.6084/m9.figshare.26598830
Tang, Q., Yu, R., Wang, Y., Xie, F., Zhang, H., Wu, C., & Fang, M. (2024) · Figshare · doi:10.6084/m9.figshare.26598821
Tang, Q., Yu, R., Wang, Y., Xie, F., Zhang, H., Wu, C., & Fang, M. (2024) · Figshare · doi:10.6084/m9.figshare.26598824
Xu, Y., Xia, D., Huang, K., & Liang, M. (2024) · Figshare · doi:10.6084/m9.figshare.26669403
Xu, Y., Xia, D., Huang, K., & Liang, M. (2024) · Figshare · doi:10.6084/m9.figshare.26669391
Tang, Q., Yu, R., Wang, Y., Xie, F., Zhang, H., Wu, C., & Fang, M. (2024) · Figshare · doi:10.6084/m9.figshare.26598803
Qianwei, X., Zeng, T., Liu, S., Cheng, H., Ma, L., & Wang, Y. (2021) · Figshare · doi:10.6084/m9.figshare.14396794
Xu, Y., Xia, D., Huang, K., & Liang, M. (2024) · Figshare · doi:10.6084/m9.figshare.26669394
Xu, Y., Xia, D., Huang, K., & Liang, M. (2024) · Figshare · doi:10.6084/m9.figshare.26669382
Tang, Q., Yu, R., Wang, Y., Xie, F., Zhang, H., Wu, C., & Fang, M. (2024) · Figshare · doi:10.6084/m9.figshare.26598794
Tang, Q., Yu, R., Wang, Y., Xie, F., Zhang, H., Wu, C., & Fang, M. (2024) · Figshare · doi:10.6084/m9.figshare.26598812
Tang, Q., Yu, R., Wang, Y., Xie, F., Zhang, H., Wu, C., & Fang, M. (2024) · Figshare · doi:10.6084/m9.figshare.26598797
Xu, Y., Xia, D., Huang, K., & Liang, M. (2024) · Figshare · doi:10.6084/m9.figshare.26669400
Tang, Q., Yu, R., Wang, Y., Xie, F., Zhang, H., Wu, C., & Fang, M. (2024) · Figshare · doi:10.6084/m9.figshare.26598806
Xu, Y., Xia, D., Huang, K., & Liang, M. (2024) · Figshare · doi:10.6084/m9.figshare.26669388
Shi, Y., Li, K., Yuan, Y., Wang, C., Yang, Z., Zuo, D., Niu, Y., 邱际亮, Li, B., Yuan, Y., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25622142
Self-citationCao, Y., Wu, C., Tong, K., Chen, Y., Chen, J., Gao, Y., Fu, Z., Wang, X., & Liu, M. (2026) · Research Square · doi:10.21203/rs.3.rs-8559986/v1
Comprehensive analysis of the potential role of Ferroptosis-related genes in glioblastoma multiforme
Guo, X., Sun, L., Jiao, H., Liu, L., Xiong, H., Tian, Z., Zeng, S., & Huo, J. (2026) · Neurological Sciences · doi:10.1007/s10072-026-08938-0
Stephens, H. R., Elkins, E., Li, J., Swalley, Z. N., Ogbonna, H. N., Muri, P., Roberts, Z. J., Dempsey, F., Ali, M. A., Siam, M. H. B., et al. (2026) · The Journal of Immunology · doi:10.1093/jimmun/vkag013
Plant virus-derived nanoparticles for the imaging and treatment of cancer
Gamper, C. (2019) · theses.fr (ABES) · doi:10.70675/844eefddz7e34z4b59z978bzda1d6c32d297
Recazens, E. (2021) · theses.fr (ABES) · doi:10.70675/5b66fe82zcbbbz4251z98c0z2bb967f598c2
Caillot, M. (2022) · theses.fr (ABES) · doi:10.70675/69fdc951z6d60z453bzbc0bz632f2f850876
Deciphering the metabolic bases of Drosophila intestinal tumors
Delamotte, P. (2024) · theses.fr (ABES) · doi:10.70675/c62595f4zbfe2z4ee5zba1az272c10f57e2a
Glycolytic Signaling Pathways and Anti‐Glycolytic Therapy for Cancer: Research and Perspectives
Li, X., Li, S., Li, D. K. T., Xi, Y., Gu, Q., Liu, J., Hou, S., Zhang, X., Jin, C., Yang, M., et al. (2026) · Comprehensive physiology · doi:10.1002/cph4.70177
Glycolysis and glycolytic enzymes in acute myeloid leukemia: Warburg and beyond
Seiler, K., Mady, Y. H., Torbett, B. E., Sarry, J., & Tschan, M. P. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1823211
Metabolic Regulation of Immune Responses: Molecular Mechanisms, Diseases, and Therapeutic Targets
Li, C., Liu, Z. H., Kong, D., Li, Z., Yan, Y., Dong, Y., Zhu, L., Cao, J., Fan, Z., Sethi, G., et al. (2026) · MedComm · doi:10.1002/mco2.70801
1H MR‐based detection of human plasma metabolic alterations in clear cell renal cell carcinoma
Sharma, R. K., Solaiyappan, M., Feinaj, A., Brönimann, S., Singla, N., Bhujwalla, Z. M., & Ged, Y. M. A. (2026) · BJUI Compass · doi:10.1002/bco2.70216
He, X., Lu, Y., Wu, P., Huang, Y., & Wang, H. (2026) · Computer Methods in Biomechanics & Biomedical Engineering · doi:10.1080/10255842.2026.2693602
Lei, X., Dong, R., Yin, L., Wu, Z., Wang, L., & He, M. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-08668-z
Hu, J., Lai, C., Xiao, Y., Yan, Z., Tan, Y., Wang, J., Qiu, J., Li, K., Yu, H., Chen, X., et al. (2026) · Oncogene · doi:10.1038/s41388-026-03946-y
Li, X., Xiong, Y., Wang, J., Qiao, W., Yu, L., Wu, J., Zhang, Y., Jin, R., & Zhang, D. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1883667
Chhetri, S. B., Winter, T., Machiela, M. J., Brown, K. M., Battle, A. J., Purdue, M. P., Chanock, S. J., & Dutta, D. (2026) · Communications Biology · doi:10.1038/s42003-026-10723-w
Mechanisms Underlying the Coordination of EMT and Glycolysis Mediated by Hypoxia and Glucose
Lu, W., Wang, H., Zhang, X., & Wang, W. (2026) · Current Issues in Molecular Biology · doi:10.3390/cimb48090907
Jiang, Y., Pagen, C., Yin, G., Zhang, Z., Wang, M., Poltorack, C. D., Xue, Y., Han, X., Coffey, N. J., Brown, M., et al. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2612523123
Self-citationTumor organoids for testing metabolic flexibility in precision oncology
Hao, D., Ren, Y., & Zhang, H. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1902688
Wang, B., Tang, Y., Li, N., Dai, X., Wu, J., Xue, B., Chen, Y., Zhang, J., Kong, L., Li, C., et al. (2026) · Advanced Science · doi:10.1002/advs.77875
Metadata
- Authors
- Li, B., Qiu, B., Lee, D. S. M., Walton, Z. E., Ochocki, J. D., Mathew, L. K., Mancuso, A., Gade, T. P. F., Keith, B., Nissim, I., & Simon, M. C.
- Affiliations
- Abramson Cancer Center (US)
- Howard Hughes Medical Institute (US)
- University of Pennsylvania (US)
- Children's Hospital of Philadelphia (US)
- Corresponding author
- Simon, M. Celeste
- ORCID
- Venue
- Nature
- Published
- 2014-07-20
- Volume
- 513
- Issue
- 7517
- Pages
- 251-255
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4162811
- OpenAlex
- W2069663698
- Cited by
- 535
- References
- 31
- Citations by year
- 2026: 24 · 2025: 38 · 2024: 44 · 2023: 44 · 2022: 48 · 2021: 64 · 2020: 54 · 2019: 42 · 2018: 54 · 2017: 42 · 2016: 40 · 2015: 33 · 2014: 6
- FWCI
- 12.92
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- National Institutes of Health
- National Cancer Institute (F30CA177106, P01CA104838, CA104838, F32CA192758, P30CA016520)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK053761, DK-053761, R56DK053761)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Health Sciences › Medicine › Oncology › Renal cell carcinoma treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- FBP1, clear cell renal cell carcinoma, von Hippel-Lindau protein, hypoxia-inducible factor, glycolysis, pentose phosphate pathway, Warburg effect, renal tubular epithelial cells, tumor progression, chromatin remodeling, cancer metabolism, epigenetic regulation, gluconeogenesis
- MeSH terms
- Animals, Carcinoma, Renal Cell, Cell Line, Epithelial Cells, Glycolysis, Fructose-Bisphosphatase, Humans, Kidney Neoplasms, Models, Molecular, NADP, Swine, Protein Structure, Tertiary, Disease Progression, Cell Line, Tumor, Cell Proliferation, Basic Helix-Loop-Helix Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review